Live · updated 4 minutes ago · 26 stories in 24h

← Stream
Stocks & Indices Unverified First seen

Ro says annualized revenue grew over tenfold after revamp and GLP-1 weight-loss push

The telehealth company Ro said its annualized revenue had grown more than tenfold since it revamped its business and embraced weight-loss treatments, according to NYT DealBook. The post attributes the growth claim to the company and ties it to GLP-1 drugs and a business revamp.

Why “Unverified”

  • Reported by NYT DealBook alone, with no second source or primary confirmation yet

1 independent source group across 1 post · evidence score 68/100. How labels work

What the sources claim

  1. Ro said its annualized revenue grew more than tenfold since it revamped its business and embraced weight-loss treatments.

    “its annualized revenue had grown more than tenfold since it revamped its business and embraced weight-loss treatments”
    NYT DealBook

Sources

More in Stocks & Indices

All Stocks & Indices stories →

Embed this page

Summary and claims extracted by AI with prompt analyze-story@5 on 2026-11-11 13:30 UTC. Labels are computed from the sources, not by the model.